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Nucleotides are important extracellular signaling
molecules. At least five mammalian P2Y receptors exist
that are specifically activated by ATP, UTP, ADP, or
UDP. Although the existence of ectoenzymes that metab-
olize extracellular nucleotides is well established, the
relative flux of ATP and UTP through their extracellular
metabolic products remains undefined. Therefore, we
have studied the kinetics of accumulation and metabo-
lism of endogenous ATP in the extracellular medium of
four different cell lines. ATP concentrations reached a
maximum immediately after change of medium and de-
creased thereafter with a single exponential decay (t½
;30–40 min). ATP levels did not fall to zero but attained
a base-line concentration that was independent of the
medium volume and of the initial ATP concentration.
Although the base-line concentration of ATP remained
stable for up to 12 h, [g-32P]ATP added to resting cells as
a radiotracer was completely degraded within 120 min,
indicating that steady state reflected a basal rate of ATP
release balanced by ATP hydrolysis (20–200 fmol 3
min21 3 cell26). High performance liquid chromatogra-
phy analysis revealed that the g-phosphate of ATP was
rapidly, although transiently, transferred during steady
state to species subsequently identified as UTP and GTP,
indicating the existence of both ecto-nucleoside diphos-
phokinase activity and the accumulation of endogenous
UDP and GDP. Conversely, addition of [g-32P]UTP to rest-
ing cells resulted in transient formation of [g-32P]ATP, in-
dicating phosphorylation of endogenous ADP by nucleo-
side diphosphokinase. The final 32P-products of [g-32P]ATP
metabolism were [32P]orthophosphoric acid and a 32P-la-
beled species that was further purified and identified as
[32P]inorganic pyrophosphate. In C6 cells, the formation of
[32P]pyrophosphate from [g-32P]ATP at steady state ex-
ceeded by 3-fold that of [32P]orthophosphate. These results
illustrate for the first time a constitutive release of ATP and
other nucleotides and reveal the existence of a complex
extracellular metabolic pathway for released nucleotides.
In addition to the existence of an ecto-ATPase activity, our
results suggest a major scavenger role of ecto-ATP pyro-
phosphatase and a transphosphorylating activity of nucle-
oside diphosphokinase.
Extracellular nucleotides regulate a broad range of cellular
responses such as platelet aggregation, vascular tone, cell pro-
liferation, mucociliary clearance, cardiac and skeletal muscle
contraction, and neurotransmission (1–4). The effects of extra-
cellular nucleotides are mediated by two large subfamilies of
receptors, the ligand-gated channel P2X receptors (P2X1–7) and
the G protein-coupled P2Y receptors (P2Y1, 2, 4, 6, 11) (4–6).
ADP, and less potently ATP, activates the P2Y1 receptor, while
ATP and UTP are the most potent agonists at the P2Y2 recep-
tor. In addition, ATP selectively activates the P2Y11 as well as
all P2X receptors. UTP is the selective agonist for the P2Y4
receptor,1 and UDP acts potently and selectively on the P2Y6
receptor (7–10). The molecular identification and the wide tis-
sue distribution of these nucleotide target proteins confirm
that both adenosine and uridine di- and triphosphates subserve
important extracellular signaling roles.
ATP is known to be released in a Ca21-dependent manner
from storage compartments in nerve terminals, chromaffin
cells, mast cells, and circulating platelets (1, 4, 11). Nucleotide
release also occurs from non-excitatory tissues, and an auto-
crine/paracrine function for extracellular adenine nucleotides
has been proposed (2, 3, 14–22). Recent studies indicate that
relatively large amounts of ATP and UTP are released by
mechanical stimulation (e.g. shear stress, hypotonic swelling,
or stretch) of epithelial and endothelial cells, smooth muscle,
glial cells, fibroblasts, and hepatocytes (14–23), and these nu-
cleotides in the extracellular medium promote a robust activa-
tion of P2 receptors (16, 21, 23–25).
Ecto-nucleotidases and other ecto-enzymes metabolize extra-
cellular ATP and UTP (26). However, the relative functional
importance of these different enzymatic activities has not been
defined for a given cell type, and little understanding is avail-
able of how these enzymes work in concert to produce the final
pattern of metabolism of nucleotides. This is an important
question given the aforementioned different selectivities of ac-
tivation of P2Y receptors by both di- and triphosphate adenine
and uridine nucleotides. As such, we have studied the kinetics
of accumulation and metabolism of endogenous ATP in the
extracellular medium of several different cell types. Our results
illustrate for the first time a “constitutive” release of nucleotide
that balances nucleotide hydrolysis and accounts for resting
levels of extracellular nucleotides. We establish that the ex-
change of the g-phosphate between adenine and uridine nucle-
otides at steady state markedly exceeds the ecto-ATPase activ-
ity. Moreover, our results highlight the importance of a
nucleotide pyrophosphatase activity and reveal that this activ-
ity approaches or exceeds that of the ecto-ATPase.
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1 ATP is not an agonist at the human P2Y4 receptor but is a potent
agonist at the rat P2Y4 homologue (11, 12).
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MATERIALS AND METHODS
Cell Culture and Incubations—C6 rat glioma, 1321N1 human astro-
cytoma, and 16HBE14o2 human bronchial epithelial cells were grown
in Dulbecco’s modified Eagle’s medium-H containing 5% fetal bovine
serum and antibiotics as described previously (23). ECV-304 human
bladder epithelial cells (27) were grown in Medium 199 and 10% fetal
bovine serum. All cultures were grown to confluence on 24-well plastic
plates (Costar). Prior to assays, the cultures were washed three times
and incubated in 0.5 ml of serum- and phenol red-free minimum essen-
tial medium (MEM).2
Luciferin-Luciferase Assay—Samples of extracellular medium were
collected and boiled for 1 min, and the luciferin-luciferase assay was
performed using a LB953 AutoLumat luminometer (Berthold GmbH),
as described previously (21). Standard curves were performed routinely
using molecular biology grade ATP, which was diluted in the same
buffer and processed (e.g. boiled) in parallel to cell samples. No loss of
ATP was observed during sample boiling. The threshold value for ATP
detection was 100 pM (5 fmol/sample), and luminescence was linear
with ATP concentration to 1000 nM.
Enzymatic Synthesis of 32P-Labeled Inorganic Pyrophosphate,
[g-32P]UTP, and [g-32P]GTP—32P-Labeled inorganic pyrophosphate
(32PPi) was obtained by incubating 1 mCi of [g-
32P]ATP (100 mM) with 2
units/ml commercial nucleotide pyrophosphatase at 30 °C for 5 min.
The quantitative conversion of [g-32P]ATP to 32PPi plus AMP was mon-
itored by HPLC. [g-32P]UTP and [g-32P]GTP were obtained by incubat-
ing 3 mCi of [g-32P]ATP (specific activity .3000 Ci/mmol) in the pres-
ence of 0.1 units/ml bovine liver nucleoside diphosphokinase (NDPK)
and 100 nM UDP or GDP, respectively, for 5 min at 30 °C (28).
Quantification of Nucleotides by HPLC—Except where indicated oth-
erwise, species were separated by HPLC (Shimadzu) via a Dynamax
C18 column (Varian) as described previously (21). The ion pairing
mobile phase consisted of 8 mM tetrabutylammonium hydrogen sulfate
(TBAHS), 17 mM KH2PO4, pH 5.3 (solvent A), or 8 mM TBAHS, 100 mM
KH2PO4, pH 5.3, and 10% methanol (solvent B). The mobile phase
developed at 1 ml/min from 0 to 4 min in 100% solvent A, and from 4 to
30 min in 100% solvent B. The elution times of authentic nucleotides
were, ATP, 23.30 min; GTP, 18.20 min; UTP, 18.15 min; CTP, 16.5 min;
ADP, 14.2 min, and AMP, 6.0 min. In some experiments (Fig. 7F), an
anion exchange system with a 3021C4.6 ion chromatography column
(Vydac, Hesperia, CA) was used, and the mobile phase (2 ml/min)
developed in 25 mM NaH2PO4, pH 2.8 (solvent A), for 2 min followed by
a linear gradient to 125 mM NH2PO4, pH 2.9 (solvent B), from 2 to 10
min. 100% solvent B was maintained from 10 to 30 min. The elution
times for GTP, ATP, and UTP were 24.7, 20.3, and 16.8 min, respec-
tively. Absorbance at l 5 260 nm was monitored on-line with an
SPD-10A UV detector (Shimadzu, Japan), and radioactivity was meas-
ured on-line with a 500TR Radiomatic analyzer (Packard, Australia), as
described previously (24). Full recovery of injected 32P counts was
routinely verified during HPLC runs.
Reagents—ATP, UTP, GTP, and CTP were purchased from Amer-
sham Pharmacia Biotech (Uppsala, Sweden). UDP, ADP, GDP, CDP,
39,59-cyclic AMP, and AMPPNP were from Roche Molecular Biochemi-
cals. AMPPCP and a,b-metATP were from RBI (Natick, MA). Bovine
liver UDP-glucose pyrophosphorylase, yeast inorganic pyrophos-
phatase, Crotalus adamateus nucleotide pyrophosphatase, yeast nucle-
oside diphosphokinase, firefly luciferase, luciferin, Ap4A, Ap5A, ADP-
glucose, ADP-ribose, and AMPPCP were obtained from Sigma.
[g-33P]ATP (.3000 Ci/mmol) was from Amersham Pharmacia Biotech.
RESULTS
Extracellular Accumulation of ATP—The kinetics of extra-
cellular accumulation of endogenous ATP and its metabolism
were examined with 16HBE14o2 human bronchial epithelial
cells, ECV-304 human bladder epithelial cells, C6 rat glioma
cells, and 1321N1 human astrocytoma cells. The growth me-
dium bathing confluent cultures was replaced with 0.5 ml of
MEM, and extracellular ATP levels were measured by the
luciferin-luciferase assay over a 12-h interval. Consistent with
ATP release secondary to mechanical stimulation of the cells
(21, 23–25), relatively large concentrations of ATP were de-
tected immediately after a change of medium, and these levels
decreased steadily with t1⁄2 values ;30–40 min (Fig. 1 and
Table I). Extracellular levels of ATP did not fall to zero but
attained a base line in the low nanomolar range within 3 h and
remained unchanged for up to 12 h (Fig. 1 and Table I).
The dependence of the ATP concentration at base line on
both the volume of the extracellular medium and the magni-
tude of the initial concentration of ATP was determined. The
concentration of ATP 1 min subsequent to a wash was 132 6 19
nM (n 5 6) for ECV-304 cells incubated in 0.5 ml of bathing
solution. Addition of 1 ml of mineral oil to the post-wash aque-
ous medium of these cells resulted in a slight increase of the
ATP concentration within 1 min (152 6 25 nM, n 5 6), possibly
reflecting additional ATP release due to the higher hydrostatic
pressure and/or medium stirring. Addition of 1 ml of aqueous
medium instead of mineral oil (i.e. the final volume of aqueous
medium was 1.5 ml) resulted in a decrease in ATP concentra-
tion to 46 6 7 nM (measured at 1 min, n 5 6), consistent with
the 1:3 dilution of the initial solution. ATP concentrations
further decayed to base-line levels that were similar in non-
diluted (0.5 ml of medium: 3.2 6 1 nM, n 5 6) and 1:3 diluted
samples (1.5 ml of medium: 2.6 6 0.4 nM, n 5 6). In the four cell
lines, addition of exogenous ATP (30 and 300 nM) to resting
cells incubated in 0.5 ml of MEM resulted with time in base-
line ATP concentrations that were indistinguishable from base-
line values of control cells (shown in Table I). The t1⁄2 values for
hydrolysis of exogenous ATP (data not shown) at both 30 and
300 nM were identical to the t1⁄2 values for endogenous ATP
shown in Table I. These results indicate that extracellular ATP
concentrations attain a constant value that is independent of
2 The abbreviations used are: MEM, minimal essential medium; PPi,
inorganic pyrophosphate; AMPPNP, adenylyl imidodiphosphate; AMP-
PCP, b,g-methylene ATP; a,b-metATP, a,b-methylene ATP; NDPK,
nucleoside diphosphokinase; Ap4A, P
1–P4-di(adenosine-59) tetraphos-
phate; Ap5A, P
1–P5-di(adenosine-59) tetraphosphate; HPLC, high per-
formance liquid chromatography; TBAHS, tetrabutylethyl ammonium
sulfate; E-NPP, ecto-nucleotide pyrophosphatase.
FIG. 1. Decay of released ATP. Confluent 16HBE14o2, ECV-304,
C6, and 1321N1 cells grown in 24-well plates were rinsed twice and
incubated in 0.5 ml of serum- and phenol red-free MEM. The medium
was removed at the indicated times, and ATP concentration was deter-
mined by the luciferase assay as described under “Materials and Meth-
ods.” The results indicate the mean 6 S.D. from at least six experiments
performed with quadruplicate samples.
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the volume of the bathing medium and of the magnitude of the
initial ATP concentration.
ATP Release at Steady State—We further examined the ca-
pacity of 16HBE14o2, ECV-304, C6, and 1321N1 cells to me-
tabolize exogenous [g-32P]ATP added after ATP concentrations
stabilized. Cells were maintained undisturbed for at least 3 h,
[g-32P]ATP then was added at high specific radioactivity, and
both the ATP concentration and [g-32P]ATP were quantified by
the luciferin-luciferase assay and HPLC analysis, respectively.
Although levels of ATP mass remained unchanged, [g-32P]ATP
was near completely metabolized within 120 min (Fig. 2). Thus,
the development of a base-line ATP concentration reflects a
steady state where hydrolysis is balanced by basal (“constitu-
tive”) release of ATP. Consequently, resting cells release ATP
at a rate that can be quantitatively deduced from the rate of
ATP hydrolysis at steady state.
The simplest approach to determine the rate of ATP release
at steady state would be to measure directly the initial rate of
[g-32P]ATP decay or, alternatively, the rate of accumulation of
[32P]orthophosphoric acid (32Pi). However, disappearance of
[g-32P]ATP does not necessarily represent hydrolysis since oc-
currence of enzyme-catalyzed exchange of the g-phosphate be-
tween ATP and co-released nucleotides (without involving 32Pi
release) may substantially affect the first segment of the
[g-32P]ATP decay curve. Moreover, 32Pi was not the sole end-
product of [g-32P]ATP metabolism (see below). The rates of ATP
hydrolysis at steady state were deduced by kinetic analysis
calculating the first order rate constant k of ATP decay (k 5
0.693/t1⁄2, Table I) and using the ATP concentrations measured
at steady state (nhydrolysis 5 k [ATP]). The nhydrolysis values
obtained ranged from ;20 to 200 fmol/min 3 1026 cells within
the four cell lines studied (Table I).
Metabolism of [g-32P]ATP—HPLC analysis of the products of
[g-32P]ATP metabolism (Fig. 3) revealed that, in addition to
32Pi, two other
32P-species appeared in the extracellular me-
dium, with retention times of 8 and 18 min (hereafter referred
to as 32P-8 and 32P-18, respectively). The 32P-18 species arose
soon after addition of [g-32P]ATP and subsequently decreased
in parallel with the decrease of [g-32P]ATP (Fig. 4). The 32P-8
species accumulated more slowly but steadily in the medium of
16HBE14o2 cells, ECV-304 cells, and 1321N1 cells. Accumula-
tion of 32P-8 was greater than accumulation of 32Pi in the
medium of C6 rat glioma cells (Figs. 3 and 4).
The metabolism of [g-32P]ATP in the medium bathing C6
cells was compared with that observed with conditioned me-
dium obtained from these cells (Fig. 5). The formation of 32P-8
and 32Pi was dependent on the presence of cells. In contrast, the
32P-18 species was generated by adding [g-32P]ATP to the cell-
free conditioned medium (Fig. 5). Similar results were observed
with ECV-304 and 16HBE14o2 cells (data not shown).
The 32P-18 species, which co-eluted with authentic standards
of GTP and UTP (Fig. 6A), was sensitive (as was [g-32P]ATP) to
acid phosphatase, but the 32P-8 species was not (Fig. 6B). The
32P-8 species, which co-eluted with authentic 32PPi, was hydro-
lyzed by inorganic pyrophosphatase, but 32P-18 and [g-32P]ATP
were not (Fig. 6C). Incubation of the 32P-species containing-
samples with C. adamateus nucleotide-pyrophosphatase (EC
3.6.1.9) resulted in conversion of both 32P-18 and [g-32P]ATP
into a 32P-species that co-eluted with 32P-8 (Fig. 6D). Therefore,
32P-18 was tentatively identified as [32P]UTP/[32P]GTP, and
32P-8 as 32PPi. These results suggest the presence of extracel-
lular nucleoside diphosphokinase (NDPK) and ecto-nucleotide
pyrophosphatase (E-NPP) activities.
Nucleoside Diphosphokinase—We previously reported the
existence of an ecto-NDPK activity in 1321N1 human astrocy-
toma cells (29). Unambiguous proof for NDPK-mediated forma-
tion of the 32P-18 species by 16HBE14o2, ECV-304, and C6
cells was obtained by three approaches. First, addition of a
molar excess of UDP (100 mM) to cells that were pre-incubated
with [g-32P]ATP for 30 min resulted in further conversion of
[32P]ATP to [32P]UTP within 5 min (with no visible changes in
the earlier 32P-species; Fig. 7B). Similarly, addition of 100 mM
CDP resulted in a shift of the radioactivity from both
[g-32P]ATP and 32P-18 to [g-32P]CTP (Fig. 7C), and addition of
100 mM ADP resulted in reversion of 32P-18 back to [g-32P]ATP
(data not shown). Second, cell-free conditioned medium was
deproteinized with trichloroacetic acid, trichloroacetic acid was
removed by ethyl ether extraction, and the solutions neutral-
ized (pH 7.4) and incubated for 10 min with [g-32P]ATP (3 nM)
in the absence or presence of 0.05 units/ml bovine liver NDPK.
No changes in [g-32P] ATP were observed in the absence of
NDPK, confirming that no endogenous activity was present
after the trichloroacetic acid extraction. Inclusion of NDPK
during incubation resulted in partial conversion of [g-32P]ATP
to 32P-18 (Fig. 7D). Thus, the endogenous transphosphorylat-
TABLE I
ATP decay to steady state
The t1⁄2 values and first order rate constants (k) of ATP decay were
obtained from the experiments described in Fig. 1 using a non-linear
regression fit for single exponential decay (SigmaPlot, Jandel Corp.).
Baseline ATP concentration ([ATP]bl) is expressed as the mean 6 S.D.
from 4-h incubation samples obtained from three experiments per-
formed in quadruplicate. The hypothetical rate of ATP hydrolysis at
steady state (nhydrolysis) was calculated as n 5 k [ATP]bl.
t1⁄2 k [ATP]bl
nhydrolysis
per 106 cells per cm22
min min21 nM fmol/min
16HBE14o2 29 0.023 1.9 6 0.4 145 17.3
ECV-304 29 0.023 2.4 6 0.6 204 20.1
C6 32 0.022 1.1 6 0.2 24 9.4
1321N1 41 0.017 4.9 6 0.9 166 32.6
FIG. 2. Stable ATP concentrations co-exist with [g-32P]ATP hy-
drolysis. Cells were rinsed and pre-incubated for 3 h in 0.5 ml of MEM.
[g-32P]ATP (0.1 mCi) was added to the medium, and samples were
collected at the indicated times. The ATP concentration was measured
by the luciferase assay and the 32P-species quantified by HPLC. The
results indicate the mean value from at least three experiments per-
formed with triplicate (luciferase assay) or duplicate samples (HPLC).
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ing activity that promotes formation of the 32P-18 species in the
cell-bathing medium could be substituted by exogenous NDPK
added to the deproteinized solutions. Third, the 32P-18 species
that co-elute as UTP and GTP on the C18 column (Fig. 7E)
were resolved as [32P]UTP (;45%) and [32P]GTP (55%), respec-
tively, by an ion chromatography column (Fig. 7F).
These findings indicate that endogenous GDP and UDP ac-
cumulate in the extracellular medium and serve as acceptor
substrates of NDPK. This notion also applies for ADP, as is
shown below.
Nucleotide Pyrophosphatase—The 32P-8 species was purified
from C6 cell medium by HPLC (Fig. 8, A and B) and positively
identified as 32PPi by incubating the purified fraction with 2
units/ml UDP-glucose pyrophosphorylase and a molar excess of
UDP-glucose. Consistent with the reaction: PPi 1 UDP-glucose
3 UTP 1 glucose-1P (23), full conversion of the 32P-8 species
into [32P]UTP was achieved under these conditions (Fig. 8C).
Since different ratios of extracellular 32PPi versus
32Pi were
observed with the different cell types studied, the possibility
that an extracellular inorganic pyrophosphatase activity was
differentially expressed in a cell-specific manner was exam-
ined. C6, 16HBE14o2, and ECV-304 cells were incubated in the
presence of 32PPi, and the resulting species accumulating in the
medium were analyzed by HPLC. Surprisingly, 32PPi remained
unchanged for up to 120 min after its addition (Fig. 8), indicat-
ing that inorganic pyrophosphatase is not expressed on the
surface of these cells. These results suggest that the relative
ratio of accumulation of PPi over Pi is determined exclusively
by the relative activities of E-NPP versus ecto-ATPase.
32PPi also was the major end product of [g -
32P]UTP on C6
cells (Fig. 9). Interestingly, the terminal phosphate of UTP was
transiently (although not completely) transferred to ATP (Fig.
9), consistent with phosphorylation of endogenous ADP by en-
dogenous NDPK. Since formation of 32PPi further proceeded
FIG. 3. Metabolism of extracellular [g-32P]ATP. Cells were rinsed
and pre-incubated as described in the legend of Fig. 2. The HPLC (C18
column) tracings are representative of at least three experiments where
[g-32P]ATP was incubated for 30 min in 0.5 ml of MEM in the absence
of cells (top panel) or the presence of the indicated cells.
FIG. 4. Time course of extracellular [g-32P]ATP metabolism.
[g-32P]ATP was added to resting cells for the indicated times and the
resulting 32P-species analyzed by HPLC. The data represent the mean
value from a single experiment with duplicate samples differing by less
than 20% from each other. Similar results were obtained in at least
three experiments performed under similar conditions. Open circle,
[g-32P]ATP; open square, 32Pi; closed square,
32P-18; closed circle, 32P-8.
FIG. 5. Metabolism of [g-32P]ATP by C6 cells and cell-free con-
ditioned medium. [g-32P]ATP was added to either resting C6 cells
(closed circle) or conditioned medium obtained from resting C6 cells
(open circle), and the resulting 32P-species were separated by HPLC.
The data represent the mean 6 S.D. from one experiment performed
with triplicate samples. The results are representative of three inde-
pendent experiments performed under similar conditions.
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after 20 min while [32P]ATP was no longer detected (Fig. 9), we
conclude that UTP is itself an efficient substrate for the forma-
tion of pyrophosphate.
Ecto-nucleotide pyrophosphatases hydrolyze dinucleoside
polyphosphates and nucleotide sugars, but also generate free
pyrophosphate (and AMP) from ATP (26). Therefore, these
enzymes are logical candidates for the ATP pyrophosphatase
activity described in this study. Although we have not meas-
ured the direct conversion of ATP to AMP as proof of principle
for E-NPP activity, conversion of [g-32P]ATP to 32PPi was ef-
fectively prevented by the E-NPP inhibitor a,b-metATP (Fig.
10) and was delayed by Ap4A, Ap5A, UDP-glucose, ADP-glu-
cose, ADP-ribose, AMPPCP, and AMPPNP (Fig. 10), all of
which are known substrates of the E-NPP family.
The kinetic constants for the ATP-dependent accumulation
of 32PPi and
32Pi on C6 cells were calculated (Table II). Al-
though Vmax values for PPi formation were about one half of
those for Pi, the PPi-generating activity exhibited a Km(app) for
ATP that was approximately 6 times lower than the Km(app) of
the ecto-ATPase activity. Thus, at steady state where [ATP] ,,
Km, the formation of PPi on C6 cells exceeds by a factor of 3 that
of Pi (determined by the Vmax/Km ratios) suggesting that E-
PPN activity is the major regulator of the extracellular levels of
nucleotides that are released by resting cells. This conclusion
also is consistent with the results described earlier (Fig. 3),
which illustrated that accumulation of 32PPi at steady state on
resting C6 cells was 3–4 times higher than accumulation of
32Pi. The Vmax/Km values for the overall ATP hydrolysis reac-
tion on C6 cells (;0.03 min21; Table II) closely approached the
first order rate constant value (k 5 0.02 min21) calculated from
the t1⁄2 values, as detailed in Fig. 1 and Table I.
DISCUSSION
In the present study, we demonstrated that basal (or “con-
stitutive”) release of ATP is a characteristic of resting cells, and
we have defined conditions that allow quantification of the
basal rate of ATP release. Both mechanically released ATP and
exogenous ATP decay to a steady state where the magnitude of
nucleotide hydrolysis and basal release are balanced. At steady
state, extracellular ATP concentrations are independent of
both the volume of the extracellular solution and the initial
ATP input. Thus, ATP concentrations in the extracellular me-
dium of resting cells are an intrinsic attribute of the tissue and
reflect a balance between the capacity of the cells to release
ATP “constitutively,” and the efficiency of the ATP-hydrolyzing
ecto-enzymes.
The basal rate of ATP release was determined based on bulk
ATP concentrations. However, ATP concentrations measured
in the entire medium are unlikely to accurately reflect the
concentration at the cell surface. ATP and UTP levels observed
in the medium bathing resting 1321N1 cells (Table I and Refs.
23 and 25) are below threshold values for stimulation of P2Y
receptors (24, 25). However, addition of apyrase or hexokinase
to resting P2Y2 or P2Y4 receptor-expressing 1321N1 cells re-
sulted in significant reduction of the basal accumulation of
inositol phosphates (21, 24, 25), suggesting that local nucleo-
tide concentrations were high enough to confer basal activity to
these receptors. These results indicate that quantification of
FIG. 6. Enzymatic identification of the 32P-8 and 32P-18 species
from C6 cells. [g-32P]ATP was added to resting C6 cells for 30 min. The
medium was removed and incubated for 5 min in the absence (A) or in
the presence of 1 unit/ml acid phosphatase (B), inorganic pyrophos-
phatase (C), or nucleotide pyrophosphatase from C. adamateus (D). The
resulting 32P-species were separated by HPLC. The elution time of
authentic standards of 32Pi,
32PPi, [g-
32P]ATP, [g-32P]UTP, and
[g-32P]GTP are indicated at the top of panel A. The tracings are repre-
sentative of at least three independent experiments performed in
duplicates.
FIG. 7. NDPK promotes the formation of [g-32P]UTP and
[g-32P]GTP. Resting C6 cells were incubated for 30 min with
[g-32P]ATP (A), after which 100 mM UDP (B) or CDP (C) were added for
5 min. Conditioned medium from C6 cells was deproteinized with tri-
chloroacetic acid and subsequently incubated for 30 min with 0.1 mCi of
[g-32P]ATP and 0.1 units/ml nucleoside diphosphokinase (D). The
HPLC tracings are representative of at least two experiments per-
formed in duplicate. In a separate experiment, resting C6 cells were
incubated for 10 min with [g-32P]ATP and the resulting species sepa-
rated by HPLC via a C18 (E) or an ion exchange column (F). The data
are representative of two independent experiments. The elution times
of 32P-labeled nucleotide standards are indicated. Similar results were
obtained with 16HBE14o2 and ECV-304 cells (data not shown).
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ATP and UTP in the bulk medium likely reflects a fraction of
the actual nucleotide mass that accumulates transiently in the
vicinity of the P2Y receptors. Consistent with this notion, using
an in situ assay for ATP whereby cell surface-bound luciferase
acts as a bioluminescent sensor for ATP, Dubyak and col-
leagues (30) recently reported that ATP concentrations in the
bulk medium of thrombin-stimulated platelets underestimate
by at least 1 order of magnitude the ATP concentration near
the cell surface.
“Constitutive” release of ATP may be physiologically rele-
vant particularly in tissues such as human airways, which are
covered by a thin layer (;1 ml/cm (Ref. 2)) of surface liquid (31).
The P2Y2 receptor of airways controls several components of
mucociliary clearance by promoting Ca21-dependent Cl2 secre-
tion, mucin secretion, and ciliary beating (31–35). Based on the
observed rate of ATP release from resting 16HBE14o2 cells
(Table I), accumulation of ATP in the periciliar airway surface
liquid would proceed at a rate of ;20 nM/min, and ATP accu-
mulation would rapidly exceed EC50 values for P2Y2 receptor
activation if substantial metabolism of nucleotide did not occur.
We speculate that basal release of ATP provides a mechanism
of activation of the P2Y2 receptor that controls physiological
functions in “resting” airways.
We reported recently that nucleotide release by mechanically
stimulated cells, which represented 0.5–10% of the intracellu-
lar pool (21, 23–25), was not associated with cell damage (as-
sayed by LDH activity, 51Cr release, or with the fluorescent
probe calcein (21, 23–25)). Resting cells release one millionth of
the total cellular ATP (23) per minute, a value far below the
FIG. 8. Identification of 32PPi. C6 cells were incubated for 30 min
in the presence of 1 mCi of [g-32P]ATP in 0.5 ml of MEM (A). The 32P-8
species was purified and further incubated for 1 h with 1 mM UDP-
glucose in the absence (B) or in the presence (C) of 2 units/ml UDP-
glucose pyrophosphorylase (21). The formation of [32P]UTP was moni-
tored by HPLC. The completeness of the reaction was confirmed in a
parallel incubation where authentic 32PPi was quantitatively converted
to [32P]UTP. D, HPLC tracings corresponding to a 2-h incubation of C6
(lll), 16HBE14o2 (- - -), or ECV-304 ( . . . ) cells with 0.5 mCi of 32PPi.
FIG. 9. Metabolism of [g-32P]UTP on C6 cells. C6 cells were incu-
bated in 0.5 ml of MEM containing 0.1 mCi of [g-32P]UTP. A, HPLC
tracings representative of t 5 0 and 10-min incubation periods. B, time
course of 32P-species accumulation. The data represent the mean value
of two experiments performed with duplicate samples that differed by
less than 20% from each other.
FIG. 10. Effect of nucleotide analogues on the formation of
32PPi. Resting C6 cells were incubated for the times indicated in the
presence of 100 mM indicated nucleotide and 0.1 mCi of [g-32P]ATP
(specific activity .3000 Ci/mmol), and the resulting 32PPi was quanti-
fied by HPLC. The results are expressed as the percentage of radioac-
tivity accumulated as 32PPi relative to initial [g-
32P]ATP. The data
represent the mean value from two different experiments performed
with duplicate samples that differed by less than 10% from each other.
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sensitivity of available assays for cell lysis. Thus, our data do
not rule out the possibility that ongoing irreversible membrane
damage of a very small number of cells may contribute to the
observed rates of ATP release. However, increasing evidence
suggests that release of cytosolic ATP is a cell-regulated proc-
ess (4, 16, 22, 36, 37), which may involve the action of gliben-
clamide-sensitive K1 channels (16), 5-nitro-2-(3phenylpro-
pylamino)benzoic acid-sensitive Cl2 channels (22, 37), and/or
phosphatidylinositol 1,4,5-trisphosphate kinase (36). It has
been speculated that ATP release occurs via members of the
ABC transporter family of proteins such as the cystic fibrosis
transmembrane regulator (38, 39), but this notion was not
sustained by a number of studies including experiments with
cystic fibrosis transmembrane regulator-deficient cells in ex-
periments where cystic fibrosis transmembrane regulator was
overexpressed in cells where the P2Y2 receptor acted as a
biosensor for ATP/UTP release (22, 27, 37, 40). Although the
mechanism whereby non-excitatory cells release nucleotides
remains unclear, basal ATP release occurs at negligible rates
compared with cellular ATP turnover and, thus, may provide a
“purinergic tone” to non-excitatory tissues without compromis-
ing the energetic balance of the cells.
The present study also illustrates the complexity of the cel-
lular pathways involved in the regulation of extracellular nu-
cleotide levels. Our results indicate that an extracellular
NDPK activity is responsible for the continuous and reversible
interchange of g-phosphate within endogenous nucleotides.
This NDPK activity is so large that transfer of [g-32P]phos-
phate from ATP to both GTP and UTP was detected in all cell
types prior to measurable accumulation of 32PPi or
32Pi. These
data are consistent with our previous kinetic analysis of NDPK
and nucleotidase activities on 1321N1 cells (29), which indi-
cated that NDPK activity exceeded by a factor of 20 that of the
ecto-nucleotidase (29). To our knowledge, this is the first ob-
servation of ecto-NDPK activity that plays an active role in the
forward and reverse transfer of the terminal phosphate of
endogenous ATP to other endogenous nucleotides, e.g. UDP.
Our results are not only consistent with our previous observa-
tion of extracellular accumulation of UTP (22, 25) but also
indicate that UDP, ADP, and GDP accumulate in amounts
comparable to those of triphosphonucleotides. Recently, we
have observed that ADP concentrations in the medium of rest-
ing C6, 16HBE14o2, ECV-304, and 1321N1 cells were at least
5 times higher than ATP concentrations at steady state (41).
Although the present study cannot rule out the possibility that
ADP and other nucleoside diphosphates are co-released with
NTPs, our previous observations with [3H]adenine-labeled
1321N1 astrocytoma and human nasal epithelial cells indi-
cated that accumulation of extracellular [3H]ADP is secondary
to [3H]ATP release and hydrolysis (21, 24). Further, studies of
[3H]ADP metabolism on the cells used in this study showed
gradual conversion to [3H]AMP and [3H]ADO without measur-
able formation of [3H]ATP, indicating that synthesis of ATP via
an ecto-adenylate kinase activity did not occur.3 Additionally,
absence of adenylate kinase activity during steady state meas-
urements was supported by the fact that no formation of
[32P]ADP was detected following the addition of [32P]ATP to
resting cells (Figs. 3 and 4). The NDPK activity not only estab-
lishes a constant ratio between the triphosphate nucleotide
signaling molecules, but also provides an extracellular ATP
regenerating system under conditions where the high energy
phosphate bond of ATP is selectively consumed, e.g. during
phosphorylation of extracellular proteins (4).
Our data indicate two extracellular pathways for ATP hy-
drolysis at steady state. Accumulation of orthophosphate along
with the higher levels of extracellular nucleoside diphosphates
relative to triphosphates (as discussed above) suggests an ecto-
nucleotidase activity with preference for NTPs over NDPs, i.e.
CD39-L1. However, 32PPi is the major end product of
[g-32P]ATP hydrolysis in C6 cells, and it accumulates signifi-
cantly on ECV-304, 16HBE14o2, and 1321N1 cells. Since the
observed Km value for PPi formation on C6 cells was ;6 times
smaller than Km values for Pi formation (Table II), we specu-
late that the PPi-generating activity (likely E-NPP) might be
important for controlling the net NTP concentrations while the
CD39-L1 activity determines the relative amounts of NTP ver-
sus NDP at steady state. A recent study suggested that PC-1
hydrolyzes ATP on C6 cells (42). Whether this E-PPN is re-
sponsible for the ATP/UTP pyrophosphatase activity described
in the present study and whether additional mechanisms are
involved in the formation of PPi remain to be determined.
The biological significance of extracellular ATP and UTP has
been supported in recent years by direct demonstration of their
release and by pharmacological studies of P2 receptors that are
potently stimulated by these nucleotides. However, a subset of
the cloned P2Y receptors, i.e. P2Y1 and P2Y6 receptors, and a
yet to be cloned Gi/adenylyl cyclase-coupled P2Y receptor are
specifically activated by nucleoside diphosphates. The con-
certed action of ecto-ATPases, which convert NTP to NDP, and
ecto-NTP pyrophosphatases, which hydrolyze NTP to AMP by-
passing the formation of NDP, offers a control mechanism for
the autocrine activation of P2Y1 and P2Y6 receptors. Our data
support the idea that nucleotide release, accumulation, and
interconversion are integrated components of resting cells.
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